TERN   $10.04  -0.30% Market Closed After Close 10.02 -0.20%

Terns Pharmaceuticals Inc
Total Cash 225.30M
totalCashPerShare 3.202
EBITDA -107.91M
Total Debt 249.00K
quickRatio 20.566
currentRatio 21.017
Total Revenue
debtToEquity 0.114
Revenue/Share
ROA -0.25987
ROE -0.38916
grossProfits
freeCashflow -46.11M
operatingCashflow -78.99M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 405.13M
forwardPE -6.8659425
floatShares 49.64M
sharesOutstanding 84.44M
sharesShort 2.66M
sharesShortPriorMonth 2.65M
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.84%
Short Ratio help_outline 2.63%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 3.109
Price To Book help_outline 3.05
earningsQuarterlyGrowth
netIncomeToCommon -95.89M
trailingEps -1.32%
forwardEps -1.38%
enterpriseToEbitda -3.75
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.34 3Q 2024
institutionsCount 175
lastUpdated Sept. 16, 2024, 8:12 p.m.